Page 298 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

272 Elizabeth J. Brant, Julie G. McGregor, J. Charles Jennette et al.

[11] Watts RA, Gonzalez-Gay MA, Lane SE, et al. Geoepidemiology of systemic vasculitis:
comparison of the incidence in two regions of Europe. Ann. Rheum. Dis. 2001; 60: 170-
172.

[12] Gibson A, Stamp LK, Chapman PT, et al. The epidemiology of Wegener's
granulomatosis and microscopic polyangiitis in a Southern Hemisphere region.
Rheumatology (Oxford) 2006; 45: 624-628.

[13] Poulton CJ, Nachman PH, Hu Y, et al. Pathways to renal biopsy and diagnosis among
patients with ANCA small-vessel vasculitis. Clin. Exp. Rheumatol. 2013; 31: S32-S37.

[14] Sokolowska B, Szczeklik W, Mastalerz L, et al. Effect of delayed diagnosis on disease
course and management of Churg-Strauss syndrome: a retrospective study. Clin.
Rheumatol. 2013; 32: 349-354.

[15] Bingham D, Muscal E, Nanda K, et al. A10: Younger Age and Severity of Renal
Presentation Distinguishes Microscopic Polyangiitis From Granulomatosis With
Polyangiitis in Children: An ARChiVe Study. Arthritis. Rheumatol. 2014; 66(Suppl
11): S15-S16.

[16] Yin XL, Zou MS, Zhang Y, et al. Twenty-three-year review of disease patterns from
renal biopsies: an experience from a pediatric renal center. J. Nephrol. 2013; 26: 699-
707.

[17] Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for
myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and
crescentic glomerulonephritis. N. Engl. J. Med. 1988; 318: 1651-1657.

[18] Jennette JC, Falk RJ, Hu P, et al. Pathogenesis of antineutrophil cytoplasmic
autoantibody-associated small-vessel vasculitis. Annu. Rev. Pathol. 2013; 8: 139-160.

[19] Bramwell B. Diffuse scleroderma: Its frequency, its occurrence in stone masons, its
treatment by fibrolysis--elevation of temperature due to fibrolysin injection. Edinburgh
Med J 1914; 12: 347-401.

[20] Miller FW, Alfredsson L, Costenbader KH, et al. Epidemiology of environmental
exposures and human autoimmune diseases: findings from a National Institute of
Environmental Health Sciences Expert Panel Workshop. J. Autoimmun. 2012; 39: 259-
271.

[21] Parks CG, Cooper GS, Nylander-French LA, et al. Occupational exposure to crystalline
silica and risk of systemic lupus erythematosus: a population-based, case-control study
in the southeastern United States. Arthritis. Rheum. 2002; 46: 1840-1850.

[22] Finckh A, Cooper GS, Chibnik LB, et al. Occupational silica and solvent exposures and
risk of systemic lupus erythematosus in urban women. Arthritis. Rheum. 2006; 54:
3648-3654.

[23] Cooper GS, Wither J, Bernatsky S, et al. Occupational and environmental exposures
and risk of systemic lupus erythematosus: silica, sunlight, solvents. Rheumatology
(Oxford) 2010; 49: 2172-2180.

[24] Hogan SL, Satterly KK, Dooley MA, et al. Silica exposure in anti-neutrophil
cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. J. Am.
Soc. Nephrol. 2001; 12: 134-142.

[25] Knight a, Sandin S, Askling J. Occupational risk factors for Wegener's granulomatosis:
a case-control study. Ann. Rheum. Dis. 2010; 69: 737-740.

Complimentary Contributor Copy